Molecular diagnosis of Huntington disease in Brazilian patients

Arquivos de Neuro-Psiquiatria

Volumn 58, Issue 1, 2000, Pages 11-17

  Lima E Silva, Tereza C ^a   Serra, Heliane Guerra ^a   Bertuzzo, Carmen S ^a   Lopes Cendes, Iscia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Involuntary movements; Molecular tests; Neurodegenerative disorders

Indexed keywords

HD PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; PROTEIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BRAZIL; CHILD; FEMALE; GENETIC MARKER; GENETICS; GENOTYPE; HUMAN; HUNTINGTON CHOREA; MALE; MIDDLE AGED; MUTATION; ONSET AGE;

ADOLESCENT; ADULT; AGE OF ONSET; ALLELES; BRAZIL; CHILD; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTEINS;

EID: 0034153618     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2000000100002     Document Type: Article

References (36)

1. Harper PS. Huntington's disease. Major Problems in Neurology, vol 31. 2Ed, London: Saunders, 1991.
2. Hayden MR. Huntigton's chorea. New York: Springer-Verlag, 1981.
3. Koroshetz WJ, and Martin JB. Huntington's disease, In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds). The molecular and genetic basis of neurological disease. Boston: Butterworth-Heinemann, 1997:545-564.
4. Martin JB, Gusella JF. Huntington's disease: pathogenesis and management. N Engl J Med 1986;315:1267-1276.
5. Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983;306:234-238.
6. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded end unstable on Huntington's disease chromosomes. Cell 1993;72:971-983.
7. De Rooji KE, De Konning Gans PAM, Skaastad MI, et al. Dynamic mutations in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range. J Med Genet 1993;30:996-1002.
8. Zühlke C, Riess O, Schröder K, et al. Expansion of the (CAG)n repeat causing Huntington's disease in 352 patients of German origin. Hum Molec Genet 1993;2:1467-1469.
9. Novelletto A, Persichetti F, Sabbadini G, et al. Analysis of the trinucleotide repeat expansion in Italian families affected with Huntington disease. Hum Mol Genet 1994;3:93-98.
10. Barron LH, Warner JP, Porteus M, et al. A study of the Huntington's disease associated trinucleotide repeat in the Scottish population. J Med Genet 1993;30:1003-1007.
11. Huq AM, Hackam A, Graham RK, Wellington CL, Hayden MR. Molecular pathogenesis of Huntington's disease: biochemical studies of huntingtin. In:Well RD, Warren ST (eds). Genetic instability and hereditary neurological diseases. San Diego: Academic Press, 1998:325-354.
12. Trottier Y, Devys D, Imbert G, et al. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet 1995;10:104-110.
13. Sharp AH, Love SJ, Schilling G, et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 1995;14:1065-1074.
14. La Spada AR, Wilson EM, Lubahn DB, et al. Androgen receptor gene mutation in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-79.
15. Zoghbi HY. The expanding world of ataxins. Nat Genet 1996;14:237-238.
16. Ross CA. When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 1995;15:493-496.
17. Koshy BT, Zoghbi HY. The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis. Brain Pathol 1997;7:927-942.
18. de Rooij KE, De Konning Gans PAM, Losekoot M, et al. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 1997;91:753-763.
19. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York. Cold Spring Harbor Laboratory Press, 1989.
20. Warner JP, Barron LB , Brck DJH. A newe polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntingyon's disease chromosomes. Molec Cell Probes 1993;7:235-239.
21. Rubinsztein DC, Leggo J, Barton DE, et al. Site of (CCG)n polymorphism in the HD gene. Nat Genet 1993;5:214-215.
22. Lopes-Cendes I, Teive HAG, Cardoso F, et al. Molecular characteristics of the Machado-Joseph disease mutation in 25 newly described Brazilian families. Braz J Genet 1997;20:717-724.
23. The American College of Medical Genetics/American Society of Human Genetics Huntington disease Genetic Testing Working Group. ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing.. Am J Hum Genet 1998;62:1243-1247.
24. Wilkinson L. SYSTAT: the system for statistics. Evanston, IL: SYSTAT, 1990.
25. Gasser T, Grabhadern K. Advances in the genetics of movement disorders: implications for molecular diagnosis. J Neurol Neurosurg Psquiatry 1997;244:341-348.
26. Rubinsztein, DC, Leggo, J, Coles R, et al. Phenotypic characterization of individuals with 30-40 CAG repeats in Huntington's disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996;59:16-22.
27. Goldberg YP, Kremer B, Andrew SE, et al. Molecular analysis of new mutations for Huntington's disease, intermediate alleles and sex of origin effects. Nat Genet 1993;5:174-179.
28. Trottier Y, Biancalana V and Mandel J-L. Instability of the CAG repeat in Huntington's disease: relation to parental transmission and age at onset. J Med Genet 1993;31:377-382.
29. Myers RH, MacDonald ME, Koroshetz WJ, et al. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease. Nat Genet 1993;5:168-173.
30. Davis MB, Bateman D, Quinn NP, Marsden CD, Harding A. Mutation analysis in patients with possible but apparently sporadic Huntington's disease. Lancet 1994;344:714-717.
31. Dürr A, Dodé C, Hahn V, et al. Diagnosis of "sporadic" Huntington's disease. J Neurol Sci 1995;129:51-55.
32. Duyao MP, Ambrose CM, Myers RH, et al. Trinucleotide repeat length: instability and age of onset in Huntington disease. Nat Genet 1993;4:387-392.
33. Brinkman RR, Mezei MM, Theilmann J, et al. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 1997;60:1202-1210.
34. World Federation of Neurology Research Committee Group on Huntington's Disease. Ethical issues policy statement on huntington's disease molecular genetics predictive test. J Med Genet 1990;17:34-38
35. The American Academy of Neurology. Consensus statement: guidelines for the molecular genetics predictive testing in Huntington's disease. Neurology 1994;44:1533-1536.
36. Benjamin CM, Adam S, Wiggins S, et al. Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet 1994;55:606-617.